Hereditas
BioMed Central Ltd · United Kingdom
Aims & Scope✦ Inferred from recent articles
This journal publishes research on the molecular mechanisms and potential therapeutic targets of various diseases, including cancers (hepatocellular carcinoma, non-small cell lung cancer, bladder cancer, cervical cancer, ovarian cancer, colorectal cancer), inflammatory and degenerative conditions (lumbar degenerative disc disease, rheumatoid arthritis, idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, osteoarthritis, aortic stenosis), and metabolic disorders (postmenopausal osteoporosis). The studies frequently investigate the roles of non-coding RNAs (like microRNAs and long non-coding RNAs), gene expression patterns, and signaling pathways in disease pathogenesis and progression. Many articles also explore the potential of natural compounds and novel biomarkers for diagnosis and treatment.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Subject Classification
Web of Science Categories
Scopus Categories
Research Topics (OpenAlex)
You May Also Like
See all →Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref